Allotrap-1258, a rationally designed immunomodulating peptide for the prevention of GvHD July 6, 1999
Renal allograft survival is prolonged by treatment with anti-CD4-idarubicin immunoconjugate July 5, 1999
First demonstration of prolonged graft survival with a rationally designed IMPDH inhibitor July 2, 1999